These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 30535476)

  • 1. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
    Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma.
    Liu J; Wang Y; Chen X; Chen X; Zhang M
    Diagn Pathol; 2024 Oct; 19(1):134. PubMed ID: 39375732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin-like protein 8, a member of cancer/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling.
    Wang L; Xing X; Tian H; Fan Q
    Tissue Cell; 2022 Apr; 75():101708. PubMed ID: 35051678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing novel long non-coding RNA FKBP9P1 represses malignant progression and inhibits PI3K/AKT signaling of head and neck squamous cell carcinoma in vitro.
    Yang YF; Feng L; Shi Q; Ma HZ; He SZ; Hou LZ; Wang R; Fang JG
    Chin Med J (Engl); 2020 Sep; 133(17):2037-2043. PubMed ID: 32769488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT3 is a key regulator of head and neck squamous cell carcinoma.
    Takahashi H; Rokudai S; Kawabata-Iwakawa R; Sakakura K; Oyama T; Nishiyama M; Chikamatsu K
    Cancer Sci; 2021 Jun; 112(6):2325-2334. PubMed ID: 33811778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway.
    Wang Q; Meng D; Shen S; Cao Y; Zhang P; Liu Y; Du L; Li H; Shao C; Dong Q
    Pathol Res Pract; 2024 Aug; 260():155481. PubMed ID: 39053135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
    Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates.
    Lu M; Xia H; Xu J; Liao Z; Li Y; Peng H
    BMC Oral Health; 2024 Oct; 24(1):1191. PubMed ID: 39375696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway.
    Yu W; Zhang Q; Ali M; Chen B; Sun Q; Wang D
    Dig Dis Sci; 2024 Oct; 69(10):3786-3798. PubMed ID: 39322809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
    García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
    Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.